Nobuyoshi Kittaka

522 total citations
30 papers, 407 citations indexed

About

Nobuyoshi Kittaka is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Nobuyoshi Kittaka has authored 30 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Cancer Research and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Nobuyoshi Kittaka's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (8 papers) and HER2/EGFR in Cancer Research (7 papers). Nobuyoshi Kittaka is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (8 papers) and HER2/EGFR in Cancer Research (7 papers). Nobuyoshi Kittaka collaborates with scholars based in Japan and United States. Nobuyoshi Kittaka's co-authors include Atsushi Inanobe, Masayuki Tanemoto, Ichiro Takemasa, Hiroaki Nagano, Shigeru Marubashi, Yutaka Takeda, Morito Monden, Keizo Dono, Shogo Kobayashi and Koji Umeshita and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Physiology and Cancer Research.

In The Last Decade

Nobuyoshi Kittaka

25 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuyoshi Kittaka Japan 8 207 128 125 77 54 30 407
Yuuki Iida Japan 13 261 1.3× 168 1.3× 120 1.0× 56 0.7× 46 0.9× 31 468
Hong-Bo Huan China 8 134 0.6× 73 0.6× 60 0.5× 35 0.5× 28 0.5× 13 324
Behyar Zoghi United States 7 214 1.0× 109 0.9× 55 0.4× 47 0.6× 48 0.9× 15 483
Min‐Goo Lee South Korea 10 236 1.1× 48 0.4× 70 0.6× 130 1.7× 55 1.0× 12 438
Can-rong Ni China 11 285 1.4× 214 1.7× 129 1.0× 33 0.4× 23 0.4× 32 427
Xinbo Qiao China 12 213 1.0× 80 0.6× 135 1.1× 63 0.8× 13 0.2× 19 407
Petra Prins United States 9 65 0.3× 49 0.4× 76 0.6× 45 0.6× 28 0.5× 25 251
Kiichiro Beppu Japan 8 159 0.8× 105 0.8× 76 0.6× 39 0.5× 31 0.6× 16 360
Futao Hou China 8 297 1.4× 164 1.3× 140 1.1× 42 0.5× 38 0.7× 11 463
Zhigang Xiao China 9 262 1.3× 227 1.8× 122 1.0× 25 0.3× 15 0.3× 27 458

Countries citing papers authored by Nobuyoshi Kittaka

Since Specialization
Citations

This map shows the geographic impact of Nobuyoshi Kittaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyoshi Kittaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyoshi Kittaka more than expected).

Fields of papers citing papers by Nobuyoshi Kittaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuyoshi Kittaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyoshi Kittaka. The network helps show where Nobuyoshi Kittaka may publish in the future.

Co-authorship network of co-authors of Nobuyoshi Kittaka

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuyoshi Kittaka. A scholar is included among the top collaborators of Nobuyoshi Kittaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuyoshi Kittaka. Nobuyoshi Kittaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nakata, Kayo, Toshitaka Morishima, Yoshihiro Kuwabara, et al.. (2023). Fifteen‐year survival and conditional survival of women with breast cancer in Osaka, Japan: A population‐based study. Cancer Medicine. 12(12). 13774–13783. 5 indexed citations
4.
Nakajima, Satomi, Tetsuhiro Yoshinami, Saki Matsui, et al.. (2022). P2-10 Effect of dose-dense doxorubicin and cyclophosphamide therapy (ddAC): A single-center retrospective analysis. Annals of Oncology. 33. S513–S513.
5.
Kittaka, Nobuyoshi, Satomi Nakajima, Saki Matsui, et al.. (2022). Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature. SHILAP Revista de lepidopterología. 8(1). 155–155. 2 indexed citations
6.
Kittaka, Nobuyoshi, et al.. (2022). Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis. Anticancer Research. 42(12). 6027–6035. 4 indexed citations
7.
8.
Nakamura, Harumi, Yoji Kukita, Kei Kunimasa, et al.. (2021). α-Methylacyl-CoA racemase: a useful immunohistochemical marker of breast carcinoma with apocrine differentiation. Human Pathology. 116. 39–48. 8 indexed citations
9.
10.
Hashimoto, Yoko, Makoto Ishitobi, Jun Okuno, et al.. (2019). Comparison of oncological outcomes in breast-conserving surgery with immediate latissimus dorsi flap reconstruction versus breast-conserving surgery alone. The Breast. 44. S108–S108. 1 indexed citations
11.
Kittaka, Nobuyoshi, Yoko Hashimoto, Kazuyoshi Motomura, et al.. (2018). A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery. International Journal of Clinical Oncology. 23(5). 860–866. 12 indexed citations
12.
Ishitobi, Makoto, et al.. (2017). Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence. Anticancer Research. 37(9). 5293–5299. 9 indexed citations
13.
Ishitobi, Makoto, et al.. (2017). pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery. Oncology. 94(1). 12–18. 2 indexed citations
14.
Ishitobi, Makoto, Jun Okuno, Nobuyoshi Kittaka, et al.. (2017). Distant recurrence risk following early ipsilateral breast tumor recurrence. Oncology Letters. 13(5). 2886–2890. 1 indexed citations
15.
Kittaka, Nobuyoshi, Ichiro Takemasa, Shigeto Seno, et al.. (2010). Exploration of Potential Genomic Portraits Associated with Intrahepatic Recurrence in Human Hepatocellular Carcinoma. Annals of Surgical Oncology. 17(12). 3145–3154. 4 indexed citations
16.
Akita, Hirofumi, Zhong Zheng, Yutaka Takeda, et al.. (2009). Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma. Oncogene. 28(32). 2903–2909. 104 indexed citations
17.
Kittaka, Nobuyoshi, Ichiro Takemasa, Yutaka Takeda, et al.. (2008). Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data. European Journal of Cancer. 44(6). 885–897. 35 indexed citations
18.
Miki, Hirofumi, Shigeyuki Tamura, Hiroshi Wada, et al.. (2003). [A case of gastric cancer with peritoneal dissemination which showed the intraperitoneal CR by administrating TS-1 orally and paclitaxel intraperitoneally].. PubMed. 30(11). 1661–4. 1 indexed citations
19.
Kittaka, Nobuyoshi, Motoi Kondo, Shoji Nakamori, et al.. (2002). A Case of Retroperitoneal Leiomyosarcoma Resected Completely with Resection of the Left Renal Vein Preserving Collateral Flow. The Japanese Journal of Gastroenterological Surgery. 35(3). 352–355.
20.
Tanemoto, Masayuki, et al.. (2000). In vivo formation of a proton‐sensitive K+ channel by heteromeric subunit assembly of Kir5.1 with Kir4.1. The Journal of Physiology. 525(3). 587–592. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuuki Iida Breakdown of academic impact, for papers by Hong-Bo Huan Breakdown of academic impact, for papers by Behyar Zoghi Breakdown of academic impact, for papers by Min‐Goo Lee Breakdown of academic impact, for papers by Can-rong Ni Breakdown of academic impact, for papers by Xinbo Qiao Breakdown of academic impact, for papers by Petra Prins Breakdown of academic impact, for papers by Kiichiro Beppu Breakdown of academic impact, for papers by Futao Hou Breakdown of academic impact, for papers by Zhigang Xiao
Rankless by CCL
2026